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Anatomists and many other medical specialists rely on clinical laboratories for 
critical information to assist in diagnosis, prognosis, and the evaluation of treatments. 
However, the clinical laboratories do not always accompany their numbers with suf-
fi cient information about the signifi cance of certain results: how great the quantita-
tive variation of a given parameter might be in healthy subjects, and how likely it 
might be that a given qualitative (“yes” or “no”) result is a false positive or false 
negative. This situation has been particularly troublesome in the case of HIV, because 
there is no “gold standard” HIV test and the typically quantitated measure, CD4, var-
ies widely for a variety of reasons that have nothing to do with HIV infection. For 
example, a person pronounced HIV-positive after having some vaccinations became 
HIV-negative again after a time, something that is not regarded as possible if HIV-
positive denotes defi nitely active infection, as is commonly assumed. An important 
consequence of defi cient information about HIV epidemiology is that students of 
anatomy may fear risking possible infection in dissection laboratories when the actual 
risk is negligible even in respect to anonymous cadavers in South Africa where the 
supposed incidence of HIV is particularly high. We have previously pointed to the 
need to improve HIV epidemiology and related public policy by recognizing and tak-
ing into account the weaknesses in HIV testing, which are the probable reason for 
at least some of the troubling conundrums and mutually contradictory data that 
seem inexplicable: conﬂ icting estimates of HIV infections and of HIV-disease deaths 
from equally authoritative sources; apparently drastically diff erent primary modes 
of transmission in diff erent geographic regions; extreme racial disparities in HIV 
infection, with Asians and Asian Americans consistently less aff ected, by about one 
third, than white Americans, while black Americans are aff ected by as much as an 
order of magnitude more than white Americans. Testing uncertainties doubtless also 
contribute to the confusion as to whether certain conditions (e.g. lipodystrophy or 
nephropathy) should be described as HIV-associated or as AIDS-associated. In recent 
work we have found that the immune system, including CD4 counts, can be mark-
edly enhanced by easily modifi ed dietary supplementation that has none of the toxic 
side-eff ects of the antiretroviral drugs currently used in the attempt to elevate CD4 
counts in HIV-positive people.
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